Neurocrine Bioscience buy UBS Group AG
Start price
09.07.25
/
50%
€113.95
Target price
09.07.26
€148.44
Performance (%)
1.10%
Price
23.01.26
€115.20
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 1.10%. This prediction currently runs until 09.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 0.964% | 0.964% |
| iShares Core DAX® | -1.764% | 2.259% |
| iShares Nasdaq 100 | -1.632% | -0.193% |
| iShares Nikkei 225® | -2.451% | 4.086% |
| iShares S&P 500 | -2.252% | -0.151% |
Comments by UBS_Group_AG for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at UBS Group AG from $152.00 to $174.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.20
23.01.26
23.01.26
€151.53
23.01.27
23.01.27
0.00%
23.01.26
23.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.80
09.10.25
09.10.25
€167.52
09.10.26
09.10.26
-3.84%
23.01.26
23.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€134.58
06.05.26
06.05.26
6.52%
23.01.26
23.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.72
04.04.25
04.04.25
€123.79
04.04.26
04.04.26
32.84%
23.01.26
23.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
08.01.25
08.01.25
€157.20
08.01.26
08.01.26
-14.59%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.45
28.05.24
28.05.24
€177.37
28.05.25
28.05.25
-13.52%
29.05.25
29.05.25